Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Supplementation in AL Amyloidosis
NCT05776940Phase 3Not yet recruiting
- Sponsor
- Air Force Medical University
- Start
- Mar 2023
- Primary completion
- Mar 2026
- Modality
- Live Biotherapeutic Products
01
Overview
A Phase 3 trial of Medilac-S in immunoglobulin light chain amyloidosis, sponsored by Air Force Medical University. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
Medilac-S
03
Conditions
immunoglobulin light chain amyloidosis
Beyond the preview
Go deeper on NCT05776940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05776940.